FDA Rejects NovoCure’s Optune Mya for Lung Cancer Brain Metastases. Here's What It Means for Investors. NASDAQ · Markets 34m ago
Accenture vs. Intuit: Does Corporate Consulting or Financial Software Make For a Better Stock Buy in 2026? NASDAQ · Markets 34m ago
Kimberly-Clark Has Raised Its Dividend for 55 Straight Years. Here's How Much $10,000 Invested Pays Annually. NASDAQ · Markets 40m ago